James Black (pharmacologist)

Sir James Whyte Black OM FRS FRSE FRCP (14 June 1924 – 22 March 2010) was a Scottish physician and pharmacologist. Together with Gertrude B. Elion and George H. Hitchings, he shared the Nobel Prize for Medicine in 1988 for pioneering strategies for rational drug-design, which, in his case, lead to the development of propranolol and cimetidine. Black established a Veterinary Physiology department at the University of Glasgow, where he became interested in the effects of adrenaline on the human heart. He went to work for ICI Pharmaceuticals in 1958 and, while there, developed propranolol, a beta blocker used for the treatment of heart disease. Black was also responsible for the development of cimetidine, an H2 receptor antagonist, a drug used to treat stomach ulcers.

Sir James Black

OM FRS FRSE FRCP
Born
James Whyte Black

(1924-06-14)14 June 1924
Uddingston, Lanarkshire, Scotland
Died22 March 2010(2010-03-22) (aged 85)
London, England
NationalityBritish
CitizenshipUnited Kingdom
Alma materUniversity of St Andrews
Known forwork towards the use of propranolol and cimetidine
Awards
Scientific career
FieldsPharmacology
Institutions
Websitewww.nobelprize.org/nobel_prizes/medicine/laureates/1988/black-bio.html
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.